Amendment issued to correct typo in annual estimates for line item 1 and to extend due date and time for receipt of offers.

Extend due date of offers

This is an unrestricted procurement for Fluticasone/Salmeterol Inhalers to supply multiple federal agencies, including the VA and DoD, with an estimated annual requirement of over 2.3 million canisters across three dosage strengths. The contract will be for one base year plus four one-year option periods. Products will be distributed through the VA and DoD Pharmaceutical Prime Vendor Programs, and the successful offeror must provide an uninterrupted supply. Specific labeling and packaging requirements are mandated, including a unique NDC number and individual boxing with barcodes. The solicitation will be issued electronically on or about February 23, 2026.